• print
  • mail
  • Home
  • Media
  • In the News
  • Amgen Initiates Voluntary Nationwide Recall of Certain Lots of
    EPOGEN® (Epoetin alfa) and PROCRIT® (Epoetin alfa)

  • Overview
  • Fact Sheets
  • Featured Content
  • Press Releases
  • Social Media
  • Media Contacts
  • In the News
  • Virtual Press Kits
ESAs in the News

Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® (Epoetin alfa) and PROCRIT® (Epoetin alfa)

On September 24, 2010, Amgen announced that certain lots of EPOGEN® and PROCRIT® vials are being voluntarily recalled from specialty distributors, wholesalers, pharmacies and healthcare providers as a precaution.

Voluntary Recall Notification Update Letter to Wholesalers and Distributors – Nov. 5, 2010

Voluntary Recall Notification Update Letter to Wholesalers and Distributors – Oct. 13, 2010

Amgen Press Release

Voluntary Recall Notification Letter to Wholesalers and Distributors

Dear Healthcare Professional Letter

Amgen distributed the Dear Healthcare Professional letter dated September 24 to select oncologists.


  • Related Links
  • Products
  • Pipeline
  • Corporate Citizenship
  • Locations
footer